One study demonstrates significantly reduced ADAMTS13 activity in HD patients compared to normal healthy controls (mean ADAMTS13 41.0 ± 22.8% vs. 102.3 ± 17.7%, respectively), which was an independent risk factor for the development of new cardiovascular events in this group of patients. Here, ADAMTS13 is linked to Huntington disease.